TSRC, Tob. Sci. Res. Conf., 2011, 65, abstr. 16
Clinical development of biomarkers of biological effect for product assessment studies.
(1) British American Tobacco, Group R&D, Southampton, UK; (2) British American Tobacco, Rome, Italy
Further tools are needed to understand how consumers use novel tobacco products, how much of the chemical yield is absorbed by the body, and how to subsequently evaluate the biological effects and health risks of novel product use. Biomarkers of...